Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy

Klin Padiatr. 2014 Nov;226(6-7):307-8. doi: 10.1055/s-0034-1389928. Epub 2014 Nov 28.
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Child
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Fluorodeoxyglucose F18
  • Follow-Up Studies
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology
  • Hodgkin Disease / radiotherapy*
  • Humans
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / prevention & control
  • Neoplasm Staging
  • Neoplasms, Radiation-Induced / etiology
  • Neoplasms, Radiation-Induced / prevention & control
  • Neoplasms, Second Primary / etiology
  • Neoplasms, Second Primary / prevention & control
  • Positron-Emission Tomography
  • Radiation Injuries / etiology
  • Radiotherapy, Adjuvant*
  • Risk Factors
  • Survival Rate
  • Vinblastine / administration & dosage
  • Young Adult

Substances

  • Fluorodeoxyglucose F18
  • Bleomycin
  • Vinblastine
  • Dacarbazine
  • Doxorubicin

Supplementary concepts

  • ABVD protocol